PROBLEM: Galectin-1 can regulate immune responses upon infection and inflammation. We determined galectin-1 expression in the chorioamniotic membranes and its changes during histological chorioamnionitis. METHOD OF STUDY: Chorioamniotic membranes were obtained from women with normal pregnancy (n = 5) and from patients with pre-term pre-labor rupture of the membranes (PPROM) with (n = 8) and without histological chorioamnionitis (n = 8). Galectin-1 mRNA and protein were localized by in situ hybridization and immunohistochemistry. Galectin-1 mRNA expression was also determined by quantitative reverse transcriptase polymerase chain reaction. RESULTS: Galectin-1 mRNA and protein were detected in the amniotic epithelium, chorioamniotic fibroblasts/myofibroblasts and macrophages, chorionic trophoblasts, and decidual stromal cells. In patients with PPROM, galectin-1 mRNA expression in the fetal membranes was higher (2.07-fold, P = 0.002) in those with chorioamnionitis than in those without. Moreover, chorioamionitis was associated with a strong galectin-1 immunostaining in amniotic epithelium, chorioamniotic mesodermal cells, and apoptotic bodies. CONCLUSION: Chorioamnionitis is associated with an increased galectin-1 mRNA expression and strong immunoreactivity of the chorioamniotic membranes; thus, galectin-1 may be involved in the regulation of the inflammatory responses to chorioamniotic infection.
PROBLEM: Galectin-1 can regulate immune responses upon infection and inflammation. We determined galectin-1 expression in the chorioamniotic membranes and its changes during histological chorioamnionitis. METHOD OF STUDY: Chorioamniotic membranes were obtained from women with normal pregnancy (n = 5) and from patients with pre-term pre-labor rupture of the membranes (PPROM) with (n = 8) and without histological chorioamnionitis (n = 8). Galectin-1 mRNA and protein were localized by in situ hybridization and immunohistochemistry. Galectin-1 mRNA expression was also determined by quantitative reverse transcriptase polymerase chain reaction. RESULTS:Galectin-1 mRNA and protein were detected in the amniotic epithelium, chorioamniotic fibroblasts/myofibroblasts and macrophages, chorionic trophoblasts, and decidual stromal cells. In patients with PPROM, galectin-1 mRNA expression in the fetal membranes was higher (2.07-fold, P = 0.002) in those with chorioamnionitis than in those without. Moreover, chorioamionitis was associated with a strong galectin-1 immunostaining in amniotic epithelium, chorioamniotic mesodermal cells, and apoptotic bodies. CONCLUSION:Chorioamnionitis is associated with an increased galectin-1 mRNA expression and strong immunoreactivity of the chorioamniotic membranes; thus, galectin-1 may be involved in the regulation of the inflammatory responses to chorioamniotic infection.
Authors: Jennifer A Fulcher; Sara T Hashimi; Ernest L Levroney; Mabel Pang; Kevin B Gurney; Linda G Baum; Benhur Lee Journal: J Immunol Date: 2006-07-01 Impact factor: 5.422
Authors: Paula Barrionuevo; Macarena Beigier-Bompadre; Juan M Ilarregui; Marta A Toscano; Germán A Bianco; Martín A Isturiz; Gabriel A Rabinovich Journal: J Immunol Date: 2007-01-01 Impact factor: 5.422
Authors: Sandra M Blois; Juan M Ilarregui; Mareike Tometten; Mariana Garcia; Arif S Orsal; Rosalia Cordo-Russo; Marta A Toscano; Germán A Bianco; Peter Kobelt; Bori Handjiski; Irene Tirado; Udo R Markert; Burghard F Klapp; Francoise Poirier; Julia Szekeres-Bartho; Gabriel A Rabinovich; Petra C Arck Journal: Nat Med Date: 2007-11-18 Impact factor: 53.440
Authors: Sung-Su Kim; Roberto Romero; Jung-Sun Kim; Asad Abbas; Jimmy Espinoza; Juan Pedro Kusanovic; Sonia Hassan; Bo Hyun Yoon; Chong Jai Kim Journal: Lab Invest Date: 2008-01-28 Impact factor: 5.662
Authors: Charles N Serhan; Sue D Brain; Christopher D Buckley; Derek W Gilroy; Christopher Haslett; Luke A J O'Neill; Mauro Perretti; Adriano G Rossi; John L Wallace Journal: FASEB J Date: 2007-02 Impact factor: 5.191
Authors: Marina I Garín; Chung-Ching Chu; Dela Golshayan; Eva Cernuda-Morollón; Robin Wait; Robert I Lechler Journal: Blood Date: 2006-11-16 Impact factor: 22.113
Authors: Peter Terness; Marinos Kallikourdis; Alexander G Betz; Gabriel A Rabinovich; Shigeru Saito; David A Clark Journal: Am J Reprod Immunol Date: 2007-09 Impact factor: 3.886
Authors: Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Giovanna Ogge; Bo Hyun Yoon; Zhong Dong; Juan M Gonzalez; Maria Teresa Gervasi; Sonia S Hassan Journal: Am J Reprod Immunol Date: 2010-02-18 Impact factor: 3.886
Authors: Vanessa Topping; Roberto Romero; Nandor Gabor Than; Adi L Tarca; Zhonghui Xu; Sun Young Kim; Bing Wang; Lami Yeo; Chong Jai Kim; Sonia S Hassan; Jung-Sun Kim Journal: J Matern Fetal Neonatal Med Date: 2012-11-23
Authors: Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Chia-Ling Nhan-Chang; Ricardo Gomez; Bo H Yoon; Lami Yeo; Pooja Mittal; Giovanna Ogge; Juan M Gonzalez; Sonia S Hassan Journal: Am J Reprod Immunol Date: 2010-01-19 Impact factor: 3.886
Authors: Sally A Madsen-Bouterse; Roberto Romero; Adi L Tarca; Juan Pedro Kusanovic; Jimmy Espinoza; Chong Jai Kim; Jung-Sun Kim; Samuel S Edwin; Ricardo Gomez; Sorin Draghici Journal: Am J Reprod Immunol Date: 2010-01 Impact factor: 3.886
Authors: Nandor Gabor Than; Roberto Romero; Offer Erez; Amy Weckle; Adi L Tarca; John Hotra; Asad Abbas; Yu Mi Han; Sung-Su Kim; Juan Pedro Kusanovic; Francesca Gotsch; Zhuocheng Hou; Joaquin Santolaya-Forgas; Kurt Benirschke; Zoltan Papp; Lawrence I Grossman; Morris Goodman; Derek E Wildman Journal: Proc Natl Acad Sci U S A Date: 2008-09-29 Impact factor: 11.205